Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro

J Tissue Eng Regen Med. 2013 Oct;7(10):767-76. doi: 10.1002/term.1465. Epub 2012 Mar 13.

Abstract

Inorganic polymeric phosphate/polyphosphate (polyP) is a natural polymer existing in both pro- and eukaryotic systems. In the present study the effect of polyP as well as of polyP supplied in a stoichiometric ratio of 2 m polyP:1 m CaCl2 [polyP (Ca(2+) complex)] on the osteoblast-like SaOS-2 cells and the osteoclast-like RAW 264.7 cells was determined. Both polymers are non-toxic for these cells up to a concentration of 100 µm. In contrast to polyP, polyP (Ca(2+) complex) significantly induced hydroxyapatite formation at a concentration > 10 µm, as documented by alizarin red S staining and scanning electron microscopic (SEM) inspection. Furthermore, polyP (Ca(2+) complex) triggered in SaOS-2 cells transcription of BMP2 (bone morphogenetic protein 2), a cytokine involved in maturation of hydroxyapatite-forming cells. An additional activity of polyP (Ca(2+) complex) is described by showing that this polymer impairs osteoclastogenesis. At concentrations > 10 µm polyP (Ca(2+) complex) slows down the progression of RAW 264.7 cells to functional osteoclasts, as measured by the expression of TRAP (tartrate-resistant acid phosphatase). Finally, it is shown that 10-100 µm polyP (Ca(2+) complex) inhibited phosphorylation of IκBα by the respective kinase in RAW 264.7 cells. We concluded that polyP (Ca(2+) complex) displays a dual effect on bone metabolizing cells. It promotes hydroxyapatite formation in SaOS-2 cells (osteoblasts) and impairs maturation of the osteoclast-related RAW 264.7 cells.

Keywords: RAW 264.7 cells; SaOS-2 cells; hydroxyapatite formation; inorganic polymeric phosphate; osteoblastogenesis; osteoblasts; osteoclastogenesis; osteoclasts; polyphosphate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthraquinones / metabolism
  • Bone Morphogenetic Protein 2 / metabolism
  • Calcification, Physiologic / drug effects
  • Cell Differentiation / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Durapatite / pharmacology
  • Humans
  • I-kappa B Proteins / metabolism
  • Mice
  • NF-KappaB Inhibitor alpha
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism
  • Osteoclasts / cytology*
  • Osteoclasts / drug effects*
  • Osteoclasts / metabolism
  • Osteogenesis / drug effects
  • Phosphorylation / drug effects
  • Polymers / pharmacology*
  • Polyphosphates / pharmacology*
  • RANK Ligand / pharmacology
  • Staining and Labeling

Substances

  • Anthraquinones
  • Bone Morphogenetic Protein 2
  • I-kappa B Proteins
  • NFKBIA protein, human
  • Nfkbia protein, mouse
  • Polymers
  • Polyphosphates
  • RANK Ligand
  • NF-KappaB Inhibitor alpha
  • alizarin
  • Durapatite